EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Picropodophyllotoxin Suppresses Factor Xa Activity, Platelet Aggregation, and Arterial Thrombosis

Gyuri Han, Ga Eun Kim, Min Seo Kim, Jaehong Kim iD, Jong-Sup Bae iD

Biomolecules · 2026

DOI: 10.3390/biom16091337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Gyuri Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Pharmaceutical Sciences, Cell & Matrix Research Institute, College of Pharmacy, Kyungpook National University, Daegu 41566, Rep…. Hauptthemen laut MEDLINE: Podophyllotoxin, Platelet Aggregation, Thrombosis, Factor Xa. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT), Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Ko…, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Picropodophyllotoxin (PPT), a naturally occurring tyrosine kinase inhibitor derived from Podophyllum hexandrum roots, is well recognized for its anticancer potential. The present study was designed to determine whether PPT exerts antithrombotic effects and to elucidate the underlying mechanisms. A range of functional assays were employed, including coagulation time measurements, platelet aggregation tests, evaluations of factor Xa activity and production, nitric oxide (NO) level assessments, and protein expression analyses. Our results demonstrated that PPT prolonged the clotting time of human platelet-poor plasma to an extent comparable to that of rivaroxaban, a reference anticoagulant, and effectively suppressed platelet aggregation induced by ADP or the thromboxane A2 mimetic U46619. Mechanistically, PPT inhibited the phosphorylation of PLCγ2 and PKC, as well as intracellular calcium mobilization—key events in platelet activation. It also downregulated the surface expression of the adhesion molecules P-selectin and PAC-1. In endothelial cells, PPT enhanced NO production while reducing endothelin-1 secretion following stimulation with ADP or U46619. Furthermore, PPT suppressed both the enzymatic activity and the cellular production of coagulation factor Xa in endothelial cells and blocked FXa-induced platelet aggregation. In murine models of thromboembolism, PPT administration significantly accelerated thrombus resolution, reduced thrombus burden and size, and improved survival rates. Collectively, these findings establish that PPT possesses potent antithrombotic activity, operating through prolongation of clotting time, inhibition of platelet aggregation, and suppression of factor Xa function—effects comparable to those of standard anticoagulants. This multifaceted mechanism positions PPT as a promising candidate for thrombosis therapy with a potentially favorable side-effect profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PodophyllotoxinPlatelet AggregationThrombosisFactor XaFactor Xa InhibitorsAnimalsHumansMiceMaleBlood CoagulationBlood Platelets

Stichwörter der Autor:innen

picropodophyllotoxinplatelet aggregationthrombosis

Substanzen

PodophyllotoxinpicropodophyllinFactor XaFactor Xa Inhibitors

Autor:innen und Institutionen

  • Research Institute of Pharmaceutical Sciences, Cell & Matrix Research Institute, College of Pharmacy, Kyungpook National University, Daegu 41566, Republic of Korea.
  • Department of Biochemistry, College of Medicine, Gachon University, Incheon 21999, Republic of Korea.

ORCID-Profile: Jaehong Kim, Jong-Sup Bae

Förderung

  • National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)
  • Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Ko…
  • National Research Foundation of Korea
  • Korea Health Industry Development Institute

Zitieren

APA

Han, G., Kim, G. E., Kim, M. S., Kim, J., & Bae, J. S. (2026). Picropodophyllotoxin Suppresses Factor Xa Activity, Platelet Aggregation, and Arterial Thrombosis. Biomolecules. https://doi.org/10.3390/biom16091337

Vancouver

Han G, Kim GE, Kim MS, Kim J, Bae JS. Picropodophyllotoxin Suppresses Factor Xa Activity, Platelet Aggregation, and Arterial Thrombosis. Biomolecules. 2026. doi:10.3390/biom16091337

BibTeX
@article{Han2026,
  author = {Han, Gyuri and Kim, Ga Eun and Kim, Min Seo and Kim, Jaehong and Bae, Jong-Sup},
  title = {Picropodophyllotoxin Suppresses Factor Xa Activity, Platelet Aggregation, and Arterial Thrombosis},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16091337}
}
Kostenlos starten →